申请人:Ciba-Geigy Corporation
公开号:US04213993A1
公开(公告)日:1980-07-22
New heterocyclylcarboxylic acid derivatives which are acylated in the nucleus, especially benz-acyl-benzimidazole-2-carboxylic acid derivatives of the formula ##STR1## in which R is a free, esterified or amidated carboxyl group or a free, etherified or esterified hydroxymethyl group, R.sub.1 is an aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic or heterocyclic-aliphatic radical, R.sub.2 is hydrogen or an aliphatic radical and Ph is a 1,2-phenylene group containing the radical R.sub.1 --C(.dbd.O)--, with the proviso that R.sub.1 contains at least 2 carbon atoms if Ph is otherwise unsubstituted, R.sub.2 is ethyl and R is acetoxymethyl, and salts of such compounds having salt-forming properties, are useful as anti-allergic agents.
新的杂环羧酸衍生物在核内进行酰化,特别是公式为##STR1##的苯乙酰基苯并咪唑-2-羧酸衍生物,其中R是自由的、酯化的或酰胺化的羧基或自由的、醚化的或酯化的羟甲基基团,R.sub.1是脂肪族、环脂族、芳香族、芳基脂肪族、杂环族或杂环脂肪族基团,R.sub.2是氢或脂肪基团,Ph是包含基团R.sub.1 --C(.dbd.O)--的1,2-苯基烷基,但前提是如果Ph未被其他基团取代,R.sub.1至少包含2个碳原子,R.sub.2是乙基,R是乙酰氧甲基,以及具有成盐性质的这些化合物的盐,可用作抗过敏剂。